review Open AccessTop 1% cited

International Variations and Trends in Renal Cell Carcinoma Incidence and Mortality

European Urology · 2014 · Vol. 67(3) · pp. 519–530

Ariana Znaor✉(Centre International de Recherche sur le Cancer)Joannie Lortet‐Tieulent(American Cancer Society)Mathieu Laversanne(Centre International de Recherche sur le Cancer)Ahmedin Jemal(American Cancer Society)Freddie Bray(Centre International de Recherche sur le Cancer)

View via DOI Publisher page

Abstract

Renal cell cancer is becoming more commonly diagnosed worldwide in both men and women. Mortality is decreasing in the most developed settings, but not in low- and middle-income countries, where access to and the availability of optimal therapies are likely to be limited.

Renal cell carcinoma treatment Multiple and Secondary Primary Cancers Renal and related cancersMedicineIncidence (geometry)DemographyPopulationRenal cell carcinomaMortality rateLatin AmericansContext (archaeology)Developed countryEnvironmental health

MeSH terms

AdolescentAdultAgedAged, 80 and overCarcinoma, Renal CellChildChild, PreschoolDeveloping CountriesFemaleHumansKidney NeoplasmsMaleMiddle AgedMortalityRisk Factors

Citations

1,009

FWCI

35.25

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

Cancer <scp>I</scp>ncidence in <scp>F</scp>ive <scp>C</scp>ontinents: Inclusion criteria, highlights from Volume X and the global status of cancer registration